,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-01-18 06:30:00,"Chicago, IL - January 18, 2017, 2016 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.014608212746679783,0.012022078968584538,0.9733696579933167,neutral,0.0025861337780952454
1,2017-01-18 06:30:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2017-01-18 06:30:00,"Stocks recently featured in the blog include Microsoft (NASDAQ: MSFT - Free Report ), Biogen (NASDAQ: BIIB - Free Report ), Home Depot (NYSE: HD - Free Report ), Bristol-Myers (NYSE: BMY - Free Report ) and Berkshire Hathaway (NYSE: BRK.B - Free Report ).",0.021519191563129425,0.01214524358510971,0.9663355350494385,neutral,0.009373947978019714
3,2017-01-18 06:30:00,"Today, Zacks is promoting its ''Buy'' stock recommendations.",0.3684377670288086,0.010614300146698952,0.6209479570388794,neutral,0.3578234612941742
4,2017-01-18 06:30:00,Get #1Stock of the Day pick for free.,0.0864095613360405,0.03249066323041916,0.8810997605323792,neutral,0.05391889810562134
5,2017-01-18 06:30:00,"Here are highlights from Tuesday's Analyst Blog:

Today's Research Daily features new research reports on 16 major stocks, including Microsoft (NASDAQ: MSFT - Free Report ), Biogen (NASDAQ: BIIB - Free Report ) and Home Depot (NYSE: HD - Free Report ).",0.01913829706609249,0.013761043548583984,0.9671006798744202,neutral,0.005377253517508507
6,2017-01-18 06:30:00,"Buy rated Microsoft shares lagged the Zacks Tech sector through the fall, but have led the way over the last three months (up +8.7% versus +3.3%) on greater appreciation for the company's reorganization and repositioning.",0.9524736404418945,0.025765087455511093,0.021761218085885048,positive,0.9267085790634155
7,2017-01-18 06:30:00,"Notably, estimates have been going up ahead of the company's Q2 earnings release.",0.47329193353652954,0.11061777174472809,0.41609030961990356,positive,0.36267417669296265
8,2017-01-18 06:30:00,"The Zacks analyst points to the company's continuing enterprise strength, benefits from the Office 365 subscription model, strong growth prospects of Azure and promising new products.",0.9253169298171997,0.013410888612270355,0.06127212569117546,positive,0.9119060635566711
9,2017-01-18 06:30:00,The recent acquisition of artificial intelligence startup Maluuba is a big positive for the company given the growing demand for artificial intelligence techniques throughout the world.,0.9154382944107056,0.013851617462933064,0.07071013003587723,positive,0.901586651802063
10,2017-01-18 06:30:00,"Further, the anticipated completion of the LinkedIn acquisition will boost Microsoft's presence in the social media market.",0.949296772480011,0.015611938200891018,0.03509132191538811,positive,0.9336848258972168
11,2017-01-18 06:30:00,"(You can read the full research report on Microsoft here>> )

Biogen shares initially gained from the post-election rally, but have since underperformed the broader pharma space as the macro issues plaguing the space still continue.",0.886441171169281,0.09425526112318039,0.019303640350699425,positive,0.79218590259552
12,2017-01-18 06:30:00,"These issues notwithstanding, the analyst likes the Buy rated stock's strong position in the multiple sclerosis market primarily due to a wide range of products.",0.6924238204956055,0.011391798965632915,0.29618436098098755,positive,0.6810320019721985
13,2017-01-18 06:30:00,Cost cutting efforts and MS franchise sales should continue to drive growth.,0.9244989156723022,0.013813234865665436,0.061687882989645004,positive,0.910685658454895
14,2017-01-18 06:30:00,"Moreover, the upcoming spin-off of the hemophilia business will allow Biogen to focus on the neurology segment, its key area of expertise.",0.6403012275695801,0.009516633115708828,0.3501821756362915,positive,0.6307845711708069
15,2017-01-18 06:30:00,Estimates have also gone up lately ahead of the Q4 earnings results.,0.8259502053260803,0.04115892946720123,0.13289088010787964,positive,0.7847912907600403
16,2017-01-18 06:30:00,The company has a positive record of earnings surprises in recent quarters.,0.9442597031593323,0.02228577248752117,0.03345456346869469,positive,0.9219739437103271
17,2017-01-18 06:30:00,"(You can read the full research report on Biogen here>> )

Buy rated Home Depot shares have outperformed the Zacks Retail sector over the last three months, gaining +7.4% over the period versus the sector's +0.8% gain in the year-to-date period.",0.90898597240448,0.0748191699385643,0.01619492471218109,positive,0.8341668248176575
18,2017-01-18 06:30:00,Solid execution and a consistent housing market recovery have been its primary growth drivers.,0.8463457822799683,0.012140084058046341,0.14151409268379211,positive,0.834205687046051
19,2017-01-18 06:30:00,"The analyst likes Home Depot's focus on developing merchandising tools, which, along with investment in building its interconnected capabilities is expected to boost its top line, and enhance market share.",0.9474795460700989,0.015217146836221218,0.03730326518416405,positive,0.9322624206542969
20,2017-01-18 06:30:00,"The company is on track to achieve its long-term dividend payout, share repurchase and return on investment targets.",0.9084774255752563,0.012517848052084446,0.07900471985340118,positive,0.8959595561027527
21,2017-01-18 06:30:00,"Estimates have been stable ahead of the company's Q4 earnings release, while it has positive record of earnings surprises in recent quarters.",0.8989883065223694,0.0522460900247097,0.048765573650598526,positive,0.8467422127723694
22,2017-01-18 06:30:00,"(You can read the full research report on Home Depot here >> )

Other noteworthy reports we are featuring today include Bristol-Myers (NYSE: BMY - Free Report ) and Berkshire Hathaway (NYSE: BRK.B - Free Report ).",0.028646165505051613,0.006473453249782324,0.9648803472518921,neutral,0.022172711789608
23,2017-01-18 06:30:00,"In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?",0.017297688871622086,0.008263223804533482,0.9744390845298767,neutral,0.009034465067088604
24,2017-01-18 06:30:00,Who wouldn't?,0.11916464567184448,0.12444141507148743,0.7563939094543457,neutral,-0.005276769399642944
25,2017-01-18 06:30:00,"These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank.",0.17488308250904083,0.010111545212566853,0.815005362033844,neutral,0.16477154195308685
26,2017-01-18 06:30:00,They are our primary picks to buy and hold.,0.06502371281385422,0.004741181619465351,0.9302350878715515,neutral,0.06028253212571144
27,2017-01-18 06:30:00,"Be among the very first to see them >>

Today, Zacks is promoting its ''Buy'' stock recommendations.",0.5071529746055603,0.012061801739037037,0.48078522086143494,positive,0.49509117007255554
28,2017-01-18 06:30:00,Get #1 Stock of the Day pick for free .,0.2226315140724182,0.024793583899736404,0.7525749206542969,neutral,0.1978379338979721
29,2017-01-18 06:30:00,Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.,0.06386703997850418,0.004654404241591692,0.9314785599708557,neutral,0.059212636202573776
30,2017-01-18 06:30:00,"Continuous coverage is provided for a universe of 1,150 publicly traded stocks.",0.036364275962114334,0.004866600502282381,0.9587691426277161,neutral,0.03149767592549324
31,2017-01-18 06:30:00,Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance.,0.054108913987874985,0.005191051866859198,0.9407000541687012,neutral,0.04891786351799965
32,2017-01-18 06:30:00,Recommendations and target prices are six-month time horizons.,0.013092893175780773,0.007127966266125441,0.9797791242599487,neutral,0.0059649269096553326
33,2017-01-18 06:30:00,"Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar.",0.044983625411987305,0.5624399185180664,0.3925764560699463,negative,-0.5174562931060791
34,2017-01-18 06:30:00,They're virtually unknown to the general public.,0.035764459520578384,0.0785161554813385,0.885719358921051,neutral,-0.04275169596076012
35,2017-01-18 06:30:00,"Yet today's 220 Zacks Rank #1 ""Strong Buys"" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015.",0.6580293774604797,0.017276067286729813,0.32469451427459717,positive,0.6407533288002014
36,2017-01-18 06:30:00,Its average gain has been a stellar +26% per year.,0.8422174453735352,0.0191669799387455,0.13861553370952606,positive,0.8230504393577576
37,2017-01-18 06:30:00,See these high-potential stocks free >>.,0.12527841329574585,0.05778927728533745,0.8169323205947876,neutral,0.0674891322851181
38,2017-01-18 06:30:00,"Get the full Report on MSFT - FREE

Get the full Report on BIIB - FREE

Get the full Report on HD - FREE

Get the full Report on BMY - FREE

Get the full Report on BRK.B - FREE

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.",0.013393394649028778,0.011144314892590046,0.9754623174667358,neutral,0.002249079756438732
39,2017-01-18 06:30:00,Past performance is no guarantee of future results.,0.023727279156446457,0.008731111884117126,0.9675416350364685,neutral,0.01499616727232933
40,2017-01-18 06:30:00,Inherent in any investment is the potential for loss.,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
41,2017-01-18 06:30:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
42,2017-01-18 06:30:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
43,2017-01-18 06:30:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
44,2017-01-18 06:30:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
45,2017-01-18 06:30:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
46,2017-01-18 06:30:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
47,2017-01-18 06:30:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
48,2017-01-18 06:30:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
49,2017-01-18 06:30:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
50,2017-01-18 06:30:00,Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01078665629029274,0.015373211354017258,0.9738401174545288,neutral,-0.004586555063724518
51,2017-01-18 06:30:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
52,2017-01-18 06:30:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
53,2017-01-18 06:30:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
54,2017-01-18 06:30:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
